Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Assessment of mitotic rate reporting in melanoma.

Burton AL, Egger ME, Gilbert JE, Stromberg AJ, Hagendoorn L, Martin RC, Scoggins CR, McMasters KM, Callender GG.

Am J Surg. 2012 Dec;204(6):969-74; discussion 974-5. doi: 10.1016/j.amjsurg.2012.05.021. Epub 2012 Oct 1.

PMID:
23036603
[PubMed - indexed for MEDLINE]
2.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103
[PubMed - indexed for MEDLINE]
3.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
[PubMed - indexed for MEDLINE]
4.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.

Ann Surg Oncol. 2003 Jun;10(5):569-74.

PMID:
12794025
[PubMed - indexed for MEDLINE]
5.

Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.

Sekula-Gibbs SA, Shearer MA.

Dermatol Surg. 2011 Aug;37(8):1080-8. doi: 10.1111/j.1524-4725.2011.02015.x. Epub 2011 Jun 2. Review.

PMID:
21635622
[PubMed - indexed for MEDLINE]
6.

Diversity of stage III melanoma in the era of sentinel lymph node biopsy.

Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR.

Ann Surg Oncol. 2013 Mar;20(3):956-63. doi: 10.1245/s10434-012-2701-z. Epub 2012 Oct 14.

PMID:
23064795
[PubMed - indexed for MEDLINE]
7.

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.

Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.

J Am Acad Dermatol. 2001 May;44(5):762-6.

PMID:
11312421
[PubMed - indexed for MEDLINE]
8.

Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.

Litzner BR, Etufugh CN, Stepenaskie S, Hynan LS, Cockerell CJ.

Am J Dermatopathol. 2012 Dec;34(8):827-32. doi: 10.1097/DAD.0b013e3182604d96.

PMID:
22878366
[PubMed - indexed for MEDLINE]
9.

Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, Alastrué A, Ferrándiz C.

Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93.

PMID:
16416605
[PubMed - indexed for MEDLINE]
10.

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM.

Ann Surg Oncol. 2004 Mar;11(3):247-58.

PMID:
14993019
[PubMed - indexed for MEDLINE]
11.

Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.

Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF.

J Clin Oncol. 2012 Jul 20;30(21):2678-83. doi: 10.1200/JCO.2011.37.8539. Epub 2012 Jun 18.

PMID:
22711850
[PubMed - indexed for MEDLINE]
Free Article
12.

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.

Cancer. 2001 Jun 15;91(12):2401-8.

PMID:
11413531
[PubMed - indexed for MEDLINE]
13.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

PMID:
20108306
[PubMed - indexed for MEDLINE]
Free Article
14.

Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.

Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.

Cancer. 2006 Nov 15;107(10):2436-45.

PMID:
17058288
[PubMed - indexed for MEDLINE]
Free Article
15.

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.

Gershenwald JE, Mansfield PF, Lee JE, Ross MI.

Ann Surg Oncol. 2000 Mar;7(2):160-5.

PMID:
10761797
[PubMed - indexed for MEDLINE]
16.

Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?

Gajdos C, Griffith KA, Wong SL, Johnson TM, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.

Cancer. 2009 Dec 15;115(24):5752-60. doi: 10.1002/cncr.24660.

PMID:
19827151
[PubMed - indexed for MEDLINE]
Free Article
17.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
[PubMed - indexed for MEDLINE]
18.

Unique prognostic factors in acral lentiginous melanoma.

Egger ME, McMasters KM, Callender GG, Quillo AR, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am J Surg. 2012 Dec;204(6):874-9; discussion 879-80. doi: 10.1016/j.amjsurg.2012.05.013. Epub 2012 Sep 28.

PMID:
23022254
[PubMed - indexed for MEDLINE]
19.

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Melanoma Res. 2003 Feb;13(1):35-43.

PMID:
12569283
[PubMed - indexed for MEDLINE]
20.

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.

Cancer. 2007 Jan 1;109(1):100-8.

PMID:
17146784
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk